Strengthening Medical Product Regulation in Low- and Middle-Income Countries
| Autor: | Mary Lou Valdez, Katherine Bond, Charles Preston |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Value (ethics)
Policy Forum Vaccines Economic growth Science Policy business.industry Supply chain lcsh:R lcsh:Medicine Developing country General Medicine Legislation Drug Globalization Pharmaceutical Preparations Work (electrical) Environmental health Global health Humans Medicine Regulatory science Product (category theory) business Developing Countries |
| Zdroj: | PLoS Medicine, Vol 9, Iss 10, p e1001327 (2012) PLoS Medicine |
| ISSN: | 1549-1676 |
| Popis: | In summary, the case studies exploring global product supply chains and diethylene glycol poisoning in Panama, clinical trials regulation through AVAREF, premarket assurance through PEPFAR tentative approval, post-market surveillance in sub-Saharan Africa through research on drug and vaccine safety systems, and regulatory science through the creation of a low-cost meningitis vaccine for low- and middle-income countries, demonstrate the essential value of regulatory systems to low- and middle-income countries. When they work, people live; when they fail, people die. As the challenges of globalization mount, and efforts to provide medical products to low- and middle-income countries scale up, there is no better time to put regulatory system strengthening squarely on the global health and development agenda. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|